Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection

Nature Medicine

Volumn 6, Issue 2, 2000, Pages 200-206

  Baba, Timothy W ^a,b,c   Liska, Vladimir ^a,b   Hofmann Lehmann, Regina ^a,b   Vlasak, Josef ^a,b   Xu, Weidong ^a,b   Ayehunie, Seyoum ^a,b,i   Cavacini, Lisa A ^b,d   Posner, Marshall R ^b,d   Katinger, Hermann ^e   Stiegler, Gabriela ^e   Bernacky, Bruce J ^f   Rizvi, Tahir A ^f   Schmidt, Russell ^f   Hill, Lori R ^f   Keeling, Michale E ^f   Lu, Yichen ^g   Wright, Joel E ^a,b   Chou, Ting Chao ^h   Ruprecht, Ruth M ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e UNIVERSITY OF AGRICULTURAL SCIENCES   (Austria)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^g HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^h MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

ⁱ MATTEK CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN G1; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 2F5; MONOCLONAL ANTIBODY 2G12; MONOCLONAL ANTIBODY F105; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPROPHYLAXIS; INFECTION PREVENTION; MACACA; NEWBORN; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; RETROVIRUS INFECTION; SIMIAN IMMUNODEFICIENCY VIRUS; TREATMENT OUTCOME; VERTICAL TRANSMISSION;

ANIMALS; ANTIBODIES, MONOCLONAL; CHIMERA; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV-1; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN G; MACACA MULATTA; NEUTRALIZATION TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; MACACA; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0033952103     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/72309     Document Type: Article

References (25)

1. Mofenson, L. & Wilfert, C. in Pediatric AIDS; The Challenge of HIV Infection in Infants, Children and Adolescents 3rd edn. (eds. Pizzo, P.A. & Wilfert, C.M.) 487-513 (Williams & Wilkins, Baltimore, Maryland, 1998).
2. Rogers M.F. Reducing the risk of maternal-infant transmission of HIV by attacking the virus. N. Engl. J. Med. 341, 441-443 (1999).
3. Williams-Herman D. et al. Risk factors for perinatal HIV-1 transmission. Abstract PO-B05-1064 (International Conference on AIDS, 6-11 June 1993).
4. Baba T.W. et al. Mucosal infection of neonatal rhesus monkeys with cell-free SIV. AIDS Res. Hum. Retroviruses 10, 351-357 (1994).
5. Li, J. et al. Persistent infection of macaques with simian-human immunodeficiency viruses. J. Virol. 69, 7061-7071 (1995).
6. Lu, Y. et al. Utility of SHIV for testing HIV-1 vaccine candidates in macaques. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 12, 99-106 (1996).
7. + by triple and quadruple combinations of human monoclonal antibodies and high-titer anti-human immunodeficiency virus type 1 immunoglobulins, J. Virol. 72, 3235-3240 (1998).
8. Posner M.R. et al. An IgG human monoclonal antibody that reacts with HIV 1 gp120, inhibits virus binding to cell, and neutralized infection. J. Immunol. 146, 4325-4332 (1991).
9. Trkola, A. et al. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J. Virol. 70, 1100-1108 (1996).
10. Muster T. et al. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J. Virol. 67, 6642-6647 (1993).
11. Mascola J.R. et al. Potent and synergistic neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by hyperimmune anti-HIV immunoglobulin combined with monoclonal antibodies 2F5 and 2G12. J. Virol. 71, 7198-7206 (1997).
12. Collman, R. et al. An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. J. Virol, 66, 7517-7521 (1992).
13. Conley A.J. et al. The consequence of passive administration of an anti-human immunodeficiency virus type 1 neutralizing monoclonal antibody before challenge of chimpanzees with a primary virus isolate. J. Virol. 70, 6751-6758 (1996).
14. Posner, M.R. Cavacini, L.A., Emes, C.L., Power, J. & Byrn, R.A. Neutralization of HIV-I by F105, a human monoclonal antibody to the CD4 binding site of gp120. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 6, 7-14 (1993).
15. Mascola, J.R. et al. Protection of macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies. J. Virol. 73, 4009-4018 (1999).
16. Liska, V. et al. Viremia and AIDS in rhesus macaques after intramuscular inoculation of plasmid DNA encoding full-length SIVmac239. AIDS Res. Hum. Retroviruses 15, 445-450 (1999).
17. Ruprecht, R.M. et al. Oral transmission of primate lentiviruses. J. Infect. Dis. 179, 5408-412 (1999).
18. Shibata, R. et al. Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys. Nature Med. 5, 204-210 (1999).
19. Joag, S.V. et al. Passively administered neutralizing serum that protected macaques against infection with parenterally inoculated pathogenic simian-human immunodeficiency virus failed to protect against mucosally inoculated virus. AIDS Res. Hum. Retroviruses 15, 391-394 (1999).
20. Van Rompay, K.K. et al. Passive immunization of newborn rhesus macaques prevents oral simian immunodeficiency virus infection. J. Infect. Dis. 177, 1247-1259 (1998).
21. Sullivan, B.L. et al. Susceptibility of HIV-1 plasma virus to complement-mediated lysis. Evidence for a role in clearance of virus in vivo. J. Immunol. 157, 1791-1798 (1996).
22. Posner, M.R., Elboim, H.S., Cannon, T., Cavacini, L. & Hideshima, T. Functional activity of an HIV-1 neutralizing IgG monoclonal antibody: ADCC and complement mediated lysis. AIDS Res. Hum. Retroviruses 8, 553-558 (1992).
23. Spouge, J.L. Statistical analysis of sparse infection data and its implications for retroviral trials in primates. Proc. Natl. Acad. Sci. USA 89, 7581-7585 (1992).
24. Baba, T.W. et al. Infection and AIDS in adult macaques after nontraumatic oral exposure to cell-free SIV. Science 272, 1486-1489 (1996).
25. Cavacini L.A. et al. Plasma pharmacokinetics and biological activity of a HIV-1 neutralizing human monoclonal antibody, F105, in cynomolgous monkeys. J. Immunotherapy 15, 251-256 (1994)